• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜黑色素瘤对丝裂霉素 C 这种链间交联剂的耐药性与 CYP450R 的表达降低有关。

Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R.

机构信息

Department of Oncology, Faculty of Medicine Dentistry and Health Sciences, The Institute for Cancer Studies, University of Sheffield, Sheffield S10 2RX, UK.

出版信息

Br J Cancer. 2011 Mar 29;104(7):1098-105. doi: 10.1038/bjc.2011.56. Epub 2011 Mar 8.

DOI:10.1038/bjc.2011.56
PMID:21386838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3068498/
Abstract

BACKGROUND

Uveal melanoma (UM) is the most common primary intraocular tumour of adults, frequently metastasising to the liver. Hepatic metastases are difficult to treat and are mainly unresponsive to chemotherapy. To investigate why UM are so chemo-resistant we explored the effect of interstrand cross-linking agents mitomycin C (MMC) and cisplatin in comparison with hydroxyurea (HU).

METHODS

Sensitivity to MMC, cisplatin and HU was tested in established UM cell lines using clonogenic assays. The response of UM to MMC was confirmed in MTT assays using short-term cultures of primary UM. The expression of cytochrome P450 reductase (CYP450R) was analysed by western blotting, and DNA cross-linking was assessed using COMET analysis supported by γ-H2AX foci formation.

RESULTS

Both established cell lines and primary cultures of UM were resistant to the cross-linking agent MMC (in each case P<0.001 in Student's t-test compared with controls). In two established UM cell lines, DNA cross-link damage was not induced by MMC (in both cases P<0.05 in Students's t-test compared with damage induced in controls). In all, 6 out of 6 UMs tested displayed reduced expression of the metabolising enzyme CYP450R and transient expression of CYP450R increased MMC sensitivity of UM.

CONCLUSION

We suggest that reduced expression of CYP450R is responsible for MMC resistance of UM, through a lack of bioactivation, which can be reversed by complementing UM cell lines with CYP450R.

摘要

背景

葡萄膜黑色素瘤(UM)是成人中最常见的原发性眼内肿瘤,常转移至肝脏。肝转移瘤难以治疗,主要对化疗无反应。为了研究为什么 UM 如此具有化疗耐药性,我们研究了丝裂霉素 C(MMC)和顺铂与羟基脲(HU)相比对视交叉连接剂的影响。

方法

采用集落形成试验检测 MMC、顺铂和 HU 在已建立的 UM 细胞系中的敏感性。在短期 UM 原代培养的 MTT 测定中证实了 UM 对 MMC 的反应。通过 Western blot 分析细胞色素 P450 还原酶(CYP450R)的表达,并通过 COMET 分析结合 γ-H2AX 焦点形成评估 DNA 交联。

结果

两种已建立的细胞系和 UM 的原代培养均对交联剂 MMC 具有耐药性(在每种情况下,与对照组相比,Student's t 检验均<0.001)。在两种已建立的 UM 细胞系中,MMC 未诱导 DNA 交联损伤(与对照组相比,在每种情况下,Student's t 检验均<0.05)。总共,在 6 个 UM 中测试的 6 个显示出代谢酶 CYP450R 的表达减少,并且 CYP450R 的瞬时表达增加了 UM 对 MMC 的敏感性。

结论

我们认为,CYP450R 的表达减少导致 UM 对 MMC 的耐药性,这是由于缺乏生物激活所致,通过用 CYP450R 补充 UM 细胞系可以逆转这种情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/78fc9143444b/bjc201156f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/723e9784c7f4/bjc201156f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/224b52e0fe04/bjc201156f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/ece93d9b122b/bjc201156f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/7ee38706de26/bjc201156f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/c229fcaba2df/bjc201156f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/78fc9143444b/bjc201156f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/723e9784c7f4/bjc201156f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/224b52e0fe04/bjc201156f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/ece93d9b122b/bjc201156f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/7ee38706de26/bjc201156f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/c229fcaba2df/bjc201156f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a0/3068498/78fc9143444b/bjc201156f6.jpg

相似文献

1
Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R.葡萄膜黑色素瘤对丝裂霉素 C 这种链间交联剂的耐药性与 CYP450R 的表达降低有关。
Br J Cancer. 2011 Mar 29;104(7):1098-105. doi: 10.1038/bjc.2011.56. Epub 2011 Mar 8.
2
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.通过病毒递送细胞色素P450还原酶可重现还原酶组成型过表达增强丝裂霉素C在人乳腺癌异种移植瘤中活性的能力。
Mol Cancer Ther. 2003 Sep;2(9):901-9.
3
Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.对一种选择出来的人膀胱癌细胞系的特性研究,该细胞系对丝裂霉素C的新型类似物BMY 25067具有抗性。
Cancer Lett. 1995 Aug 16;95(1-2):49-56. doi: 10.1016/0304-3835(95)03864-s.
4
DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.DT-黄递酶作为人结肠和胃癌细胞系对丝裂霉素C敏感性的关键决定因素。
Cancer Res. 1996 Jun 15;56(12):2823-6.
5
Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.甲磺酸伊马替尼耐药的机制在 KIT 阳性转移性葡萄膜黑素瘤。
Clin Exp Metastasis. 2014 Jun;31(5):553-64. doi: 10.1007/s10585-014-9649-2. Epub 2014 Mar 21.
6
[Mechanism of resistance to mitomycin C in a human bladder cancer cell line].[人膀胱癌细胞系对丝裂霉素C的耐药机制]
Zhonghua Zhong Liu Za Zhi. 1995 Sep;17(5):343-6.
7
Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.丝裂霉素C的肿瘤特异性协同治疗:生物还原激活的调节
Hiroshima J Med Sci. 1997 Jun;46(2):67-73.
8
Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy.人浅表性膀胱肿瘤中NAD(P)H:醌氧化还原酶和NADPH细胞色素P450还原酶的免疫组织化学分析:膀胱内丝裂霉素C治疗后肿瘤酶学与临床结果的关系
Int J Cancer. 2004 May 1;109(5):703-9. doi: 10.1002/ijc.20005.
9
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.PRAME作为转移性葡萄膜黑色素瘤免疫治疗的潜在靶点
JAMA Ophthalmol. 2017 Jun 1;135(6):541-549. doi: 10.1001/jamaophthalmol.2017.0729.
10
Molecular targeting of mitomycin C chemotherapy.丝裂霉素C化疗的分子靶向
Int J Cancer. 1997 Aug 7;72(4):649-56. doi: 10.1002/(sici)1097-0215(19970807)72:4<649::aid-ijc17>3.0.co;2-6.

引用本文的文献

1
TRP channel-related LncRNAs, AC092535.4 and LINC01637, as novel prognostic biomarkers for uveal melanoma.与瞬时受体电位(TRP)通道相关的长链非编码RNA(lncRNA)AC092535.4和LINC01637,作为葡萄膜黑色素瘤的新型预后生物标志物。
Front Genet. 2024 Jul 23;15:1441732. doi: 10.3389/fgene.2024.1441732. eCollection 2024.
2
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.葡萄膜黑色素瘤免疫和基质预后标志物的建立和验证,以指导临床治疗。
Aging (Albany NY). 2020 Oct 26;12(20):20254-20267. doi: 10.18632/aging.103779.
3
Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.

本文引用的文献

1
The in vivo toxicity of hydroxyurea depends on its direct target catalase.羟基脲的体内毒性取决于其直接靶点过氧化氢酶。
J Biol Chem. 2010 Jul 9;285(28):21411-5. doi: 10.1074/jbc.M110.103564. Epub 2010 May 7.
2
Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.葡萄膜黑色素瘤肝转移:肝动脉灌注顺铂、长春碱和达卡巴嗪的临床经验
Hepatogastroenterology. 2009 Jul-Aug;56(93):1157-62.
3
Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.
非同源末端连接增加使DNA依赖蛋白激酶成为葡萄膜黑色素瘤治疗干预的一个有前景的靶点。
Cancers (Basel). 2019 Aug 30;11(9):1278. doi: 10.3390/cancers11091278.
4
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.靶向葡萄糖转运蛋白 1 介导的代谢和转移的 EF24 在卵巢癌细胞中的治疗作用。
Cancer Sci. 2013 Dec;104(12):1690-6. doi: 10.1111/cas.12293. Epub 2013 Nov 12.
5
Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.FANCD2 减少会影响葡萄膜黑素瘤和范可尼贫血中自发的 SCE 和 RAD51 焦点形成。
Oncogene. 2013 Nov 14;32(46):5338-46. doi: 10.1038/onc.2012.627. Epub 2013 Jan 14.
葡萄膜黑色素瘤肝转移:肝动脉化疗栓塞术后生存的血管造影模式预测
Arch Ophthalmol. 2009 May;127(5):628-32. doi: 10.1001/archophthalmol.2009.45.
4
Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.经动脉化疗栓塞术(TACE)治疗葡萄膜恶性黑色素瘤肝转移的初步经验:局部肿瘤控制与生存情况
J Cancer Res Clin Oncol. 2007 Mar;133(3):177-84. doi: 10.1007/s00432-006-0155-z. Epub 2006 Oct 5.
5
Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.局部化疗在结膜和角膜原发性获得性黑变病及恶性黑色素瘤中的作用:证据综述与治疗建议
Clin Exp Ophthalmol. 2006 Sep-Oct;34(7):708-14. doi: 10.1111/j.1442-9071.2006.01356.x.
6
Metastatic uveal melanoma therapy: current options.转移性葡萄膜黑色素瘤治疗:当前的选择
Int Ophthalmol Clin. 2006 Winter;46(1):151-66. doi: 10.1097/01.iio.0000195852.08453.de.
7
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.顺铂、吉西他滨和曲奥舒凡治疗转移性葡萄膜黑色素瘤患者的II期试验
Melanoma Res. 2005 Jun;15(3):205-7. doi: 10.1097/00008390-200506000-00010.
8
Uveal melanoma: epidemiologic aspects.葡萄膜黑色素瘤:流行病学方面
Ophthalmol Clin North Am. 2005 Mar;18(1):75-84, viii. doi: 10.1016/j.ohc.2004.07.002.
9
Very long-term prognosis of patients with malignant uveal melanoma.恶性葡萄膜黑色素瘤患者的极长期预后
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9. doi: 10.1167/iovs.03-0538.
10
Cisplatin: mode of cytotoxic action and molecular basis of resistance.顺铂:细胞毒性作用模式及耐药性的分子基础
Oncogene. 2003 Oct 20;22(47):7265-79. doi: 10.1038/sj.onc.1206933.